Cargando…

Recording type 2 diabetes mellitus in a standardised central Saudi database: a retrospective validation study

OBJECTIVES: This study was conducted to assess the validity of recording (and the original diagnostic practice) of type 2 diabetes mellitus at a hospital whose records were integrated to a centralised database (the standardised common data model (CDM) of the Saudi National Pharmacoepidemiologic Data...

Descripción completa

Detalles Bibliográficos
Autores principales: Althunian, Turki Abdulaziz, Alrasheed, Meshael M, Alnofal, Fatemah A, Tafish, Rawan T, Mira, Mahmood A, Alroba, Raseel A, Kirdas, Mohammed W, Alshammari, Thamir M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032409/
https://www.ncbi.nlm.nih.gov/pubmed/36944455
http://dx.doi.org/10.1136/bmjopen-2022-065468
_version_ 1784910792947138560
author Althunian, Turki Abdulaziz
Alrasheed, Meshael M
Alnofal, Fatemah A
Tafish, Rawan T
Mira, Mahmood A
Alroba, Raseel A
Kirdas, Mohammed W
Alshammari, Thamir M
author_facet Althunian, Turki Abdulaziz
Alrasheed, Meshael M
Alnofal, Fatemah A
Tafish, Rawan T
Mira, Mahmood A
Alroba, Raseel A
Kirdas, Mohammed W
Alshammari, Thamir M
author_sort Althunian, Turki Abdulaziz
collection PubMed
description OBJECTIVES: This study was conducted to assess the validity of recording (and the original diagnostic practice) of type 2 diabetes mellitus at a hospital whose records were integrated to a centralised database (the standardised common data model (CDM) of the Saudi National Pharmacoepidemiologic Database (NPED)). DESIGN: A retrospective single-centre validation study. SETTINGS: Data of the study participants were extracted from the CDM of the NPED (only records of one tertiary care hospital were integrated at the time of the study) between 1 January 2013 and 1 July 2018. PARTICIPANTS: A random sample of patients with type 2 diabetes mellitus (≥18 years old and with a code of type 2 diabetes mellitus) matched with a control group (patients without diabetes) based on age and sex. OUTCOME MEASURES: The standardised coding of type 2 diabetes in the CDM was validated by comparing the presence of diabetes in the CDM versus the original electronic records at the hospital, the recording in paper-based medical records, and the physician re-assessment of diabetes in the included cases and controls, respectively. Sensitivity, specificity, positive predictive value and negative predictive value were estimated for each pairwise comparison using RStudio V.1.4.1103. RESULTS: A total of 437 random sample of patients with type 2 diabetes mellitus was identified and matched with 437 controls. Only 190 of 437 (43.0%) had paper-based medical records. All estimates were above 90% except for sensitivity and specificity of CDM versus paper-based records (54%; 95% CI 47% to 61% and 68%; 95% CI 62% to 73%, respectively). CONCLUSIONS: This study provided an assessment to the extent of which only type 2 diabetes mellitus code can be used to identify patients with this disease at a Saudi centralised database. A future multi-centre study would help adding more emphasis to the study findings.
format Online
Article
Text
id pubmed-10032409
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-100324092023-03-23 Recording type 2 diabetes mellitus in a standardised central Saudi database: a retrospective validation study Althunian, Turki Abdulaziz Alrasheed, Meshael M Alnofal, Fatemah A Tafish, Rawan T Mira, Mahmood A Alroba, Raseel A Kirdas, Mohammed W Alshammari, Thamir M BMJ Open Epidemiology OBJECTIVES: This study was conducted to assess the validity of recording (and the original diagnostic practice) of type 2 diabetes mellitus at a hospital whose records were integrated to a centralised database (the standardised common data model (CDM) of the Saudi National Pharmacoepidemiologic Database (NPED)). DESIGN: A retrospective single-centre validation study. SETTINGS: Data of the study participants were extracted from the CDM of the NPED (only records of one tertiary care hospital were integrated at the time of the study) between 1 January 2013 and 1 July 2018. PARTICIPANTS: A random sample of patients with type 2 diabetes mellitus (≥18 years old and with a code of type 2 diabetes mellitus) matched with a control group (patients without diabetes) based on age and sex. OUTCOME MEASURES: The standardised coding of type 2 diabetes in the CDM was validated by comparing the presence of diabetes in the CDM versus the original electronic records at the hospital, the recording in paper-based medical records, and the physician re-assessment of diabetes in the included cases and controls, respectively. Sensitivity, specificity, positive predictive value and negative predictive value were estimated for each pairwise comparison using RStudio V.1.4.1103. RESULTS: A total of 437 random sample of patients with type 2 diabetes mellitus was identified and matched with 437 controls. Only 190 of 437 (43.0%) had paper-based medical records. All estimates were above 90% except for sensitivity and specificity of CDM versus paper-based records (54%; 95% CI 47% to 61% and 68%; 95% CI 62% to 73%, respectively). CONCLUSIONS: This study provided an assessment to the extent of which only type 2 diabetes mellitus code can be used to identify patients with this disease at a Saudi centralised database. A future multi-centre study would help adding more emphasis to the study findings. BMJ Publishing Group 2023-03-21 /pmc/articles/PMC10032409/ /pubmed/36944455 http://dx.doi.org/10.1136/bmjopen-2022-065468 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Epidemiology
Althunian, Turki Abdulaziz
Alrasheed, Meshael M
Alnofal, Fatemah A
Tafish, Rawan T
Mira, Mahmood A
Alroba, Raseel A
Kirdas, Mohammed W
Alshammari, Thamir M
Recording type 2 diabetes mellitus in a standardised central Saudi database: a retrospective validation study
title Recording type 2 diabetes mellitus in a standardised central Saudi database: a retrospective validation study
title_full Recording type 2 diabetes mellitus in a standardised central Saudi database: a retrospective validation study
title_fullStr Recording type 2 diabetes mellitus in a standardised central Saudi database: a retrospective validation study
title_full_unstemmed Recording type 2 diabetes mellitus in a standardised central Saudi database: a retrospective validation study
title_short Recording type 2 diabetes mellitus in a standardised central Saudi database: a retrospective validation study
title_sort recording type 2 diabetes mellitus in a standardised central saudi database: a retrospective validation study
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032409/
https://www.ncbi.nlm.nih.gov/pubmed/36944455
http://dx.doi.org/10.1136/bmjopen-2022-065468
work_keys_str_mv AT althunianturkiabdulaziz recordingtype2diabetesmellitusinastandardisedcentralsaudidatabasearetrospectivevalidationstudy
AT alrasheedmeshaelm recordingtype2diabetesmellitusinastandardisedcentralsaudidatabasearetrospectivevalidationstudy
AT alnofalfatemaha recordingtype2diabetesmellitusinastandardisedcentralsaudidatabasearetrospectivevalidationstudy
AT tafishrawant recordingtype2diabetesmellitusinastandardisedcentralsaudidatabasearetrospectivevalidationstudy
AT miramahmooda recordingtype2diabetesmellitusinastandardisedcentralsaudidatabasearetrospectivevalidationstudy
AT alrobaraseela recordingtype2diabetesmellitusinastandardisedcentralsaudidatabasearetrospectivevalidationstudy
AT kirdasmohammedw recordingtype2diabetesmellitusinastandardisedcentralsaudidatabasearetrospectivevalidationstudy
AT alshammarithamirm recordingtype2diabetesmellitusinastandardisedcentralsaudidatabasearetrospectivevalidationstudy